Apple to sell some watches without blood oxygen feature after US court ruling

Go back to Apple to sell some watches without blood oxygen feature after US court ruling

Evercore ISI Adds Apple (AAPL) to Tactical Outperform List

January 19, 2024 6:35 AM EST

Evercore ISI analyst Amit Daryanani reiterated an Outperform rating and $220.00 price target on Apple (NASDAQ: AAPL).

The analyst comments "Apple stock has underperformed over the last few weeks (YTD down 2% vs. S&P500 down 0.2%) driven by worries ranging from China demand to watch bans to regulatory risk. We think Apple should be able to report modest upside to Dec-qtr and guide March-qtr in the zip-code of street expectations gross-margins could be a wild card in march-qtr, street is modelling GMs flat in March q/q (historically AAPL has guide for... More